Anders Jarneborn

404 total citations
19 papers, 322 citations indexed

About

Anders Jarneborn is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Anders Jarneborn has authored 19 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Anders Jarneborn's work include Antimicrobial Resistance in Staphylococcus (10 papers), Immune Response and Inflammation (9 papers) and Orthopedic Infections and Treatments (5 papers). Anders Jarneborn is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Immune Response and Inflammation (9 papers) and Orthopedic Infections and Treatments (5 papers). Anders Jarneborn collaborates with scholars based in Sweden, China and Germany. Anders Jarneborn's co-authors include Tao Jin, Manli Na, Abukar Ali, Majd Mohammad, Zhicheng Hu, Rille Pullerits, Eric Carlström, Friedrich Götz, Inger Ekman and Lars‐Eric Olsson and has published in prestigious journals such as Applied and Environmental Microbiology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anders Jarneborn

19 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Jarneborn Sweden 11 113 107 102 95 45 19 322
Tina Møller Sørensen Denmark 13 85 0.8× 59 0.6× 118 1.2× 38 0.4× 36 0.8× 24 463
Gregory J. Botwin United States 8 141 1.2× 119 1.1× 65 0.6× 21 0.2× 35 0.8× 13 336
Uma Shanmugasundaram United States 12 142 1.3× 145 1.4× 36 0.4× 21 0.2× 53 1.2× 24 377
Fériel Bouzid Tunisia 9 81 0.7× 21 0.2× 41 0.4× 50 0.5× 57 1.3× 23 241
Roberto Castronari Italy 8 88 0.8× 68 0.6× 59 0.6× 35 0.4× 74 1.6× 13 345
R Daum United States 12 218 1.9× 42 0.4× 110 1.1× 147 1.5× 80 1.8× 29 504
Joaquín López‐Contreras Spain 12 89 0.8× 28 0.3× 39 0.4× 133 1.4× 48 1.1× 33 399
Fengyan Pei China 10 105 0.9× 29 0.3× 90 0.9× 31 0.3× 28 0.6× 19 351
Guillaume Carrier France 6 36 0.3× 24 0.2× 157 1.5× 72 0.8× 10 0.2× 13 285
Duha Al‐Zubeidi United States 8 234 2.1× 84 0.8× 116 1.1× 15 0.2× 39 0.9× 10 363

Countries citing papers authored by Anders Jarneborn

Since Specialization
Citations

This map shows the geographic impact of Anders Jarneborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Jarneborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Jarneborn more than expected).

Fields of papers citing papers by Anders Jarneborn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Jarneborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Jarneborn. The network helps show where Anders Jarneborn may publish in the future.

Co-authorship network of co-authors of Anders Jarneborn

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Jarneborn. A scholar is included among the top collaborators of Anders Jarneborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Jarneborn. Anders Jarneborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jarneborn, Anders, Pradeep Kumar Kopparapu, & Tao Jin. (2025). The Dual-Edged Sword: Risks and Benefits of JAK Inhibitors in Infections. Pathogens. 14(4). 324–324. 2 indexed citations
2.
Hu, Zhicheng, Anders Jarneborn, Miriam Bollmann, et al.. (2025). Combination treatment with anti-RANKL and antibiotics for preventing joint destruction in septic arthritis. JCI Insight. 10(6). 1 indexed citations
3.
Jarneborn, Anders, et al.. (2024). Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International Journal of Molecular Sciences. 25(13). 7456–7456. 1 indexed citations
4.
Hu, Zhicheng, Pradeep Kumar Kopparapu, Anders Jarneborn, et al.. (2023). The Impact of Aging and Toll-like Receptor 2 Deficiency on the Clinical Outcomes of Staphylococcus aureus Bacteremia. The Journal of Infectious Diseases. 228(3). 332–342. 10 indexed citations
5.
Subhash, Santhilal, Zhicheng Hu, Majd Mohammad, et al.. (2023). Gene expression of S100a8/a9 predicts Staphylococcus aureus-induced septic arthritis in mice. Frontiers in Microbiology. 14. 1146694–1146694. 3 indexed citations
6.
Hu, Zhicheng, Pradeep Kumar Kopparapu, Patrick Ebner, et al.. (2022). Phenol-soluble modulin α and β display divergent roles in mice with staphylococcal septic arthritis. Communications Biology. 5(1). 910–910. 9 indexed citations
7.
Schultz, Michelle, Majd Mohammad, Minh‐Thu Nguyen, et al.. (2022). Lipoproteins Cause Bone Resorption in a Mouse Model of Staphylococcus aureus Septic Arthritis. Frontiers in Microbiology. 13. 843799–843799. 9 indexed citations
8.
Krzyżowska, Małgorzata, et al.. (2022). Tofacitinib Treatment in Primary Herpes Simplex Encephalitis Interferes With Antiviral Response. The Journal of Infectious Diseases. 225(9). 1545–1553. 9 indexed citations
9.
Jarneborn, Anders, Minh‐Thu Nguyen, Paula M. Tribelli, et al.. (2022). From an Hsp90 - binding protein to a peptide drug. PubMed. 4. uqac023–uqac023. 1 indexed citations
10.
Mohammad, Majd, Manli Na, Zhicheng Hu, et al.. (2021). Staphylococcus aureus lipoproteins promote abscess formation in mice, shielding bacteria from immune killing. Communications Biology. 4(1). 432–432. 17 indexed citations
11.
Jarneborn, Anders, Majd Mohammad, Cecilia Engdahl, et al.. (2020). Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice. Scientific Reports. 10(1). 10891–10891. 23 indexed citations
12.
Mohammad, Majd, Zhicheng Hu, Abukar Ali, et al.. (2020). The role of Staphylococcus aureus lipoproteins in hematogenous septic arthritis. Scientific Reports. 10(1). 7936–7936. 23 indexed citations
13.
14.
Mohammad, Majd, Minh‐Thu Nguyen, Cecilia Engdahl, et al.. (2019). The YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus. PLoS Pathogens. 15(6). e1007877–e1007877. 30 indexed citations
15.
Baranwal, Gaurav, Majd Mohammad, Anders Jarneborn, et al.. (2017). Impact of cell wall peptidoglycan O- acetylation on the pathogenesis of Staphylococcus aureus in septic arthritis. International Journal of Medical Microbiology. 307(7). 388–397. 22 indexed citations
16.
Na, Manli, Anders Jarneborn, Abukar Ali, et al.. (2016). Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice. Infection and Immunity. 84(4). 930–939. 33 indexed citations
17.
Ali, Abukar, Amanda Welin, Mattias N. D. Svensson, et al.. (2015). CTLA4 Immunoglobulin but Not Anti–Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice. The Journal of Infectious Diseases. 212(8). 1308–1316. 35 indexed citations
18.
Kwieciński, Jakub, Manli Na, Anders Jarneborn, et al.. (2015). Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation. Applied and Environmental Microbiology. 82(1). 394–401. 26 indexed citations
19.
Carlström, Eric, et al.. (2014). Experiences of person-centred care - patients’ perceptions: qualitative study. BMC Nursing. 13(1). 28–28. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tina Møller Sørensen Breakdown of academic impact, for papers by Gregory J. Botwin Breakdown of academic impact, for papers by Uma Shanmugasundaram Breakdown of academic impact, for papers by Fériel Bouzid Breakdown of academic impact, for papers by Roberto Castronari Breakdown of academic impact, for papers by R Daum Breakdown of academic impact, for papers by Joaquín López‐Contreras Breakdown of academic impact, for papers by Fengyan Pei Breakdown of academic impact, for papers by Guillaume Carrier Breakdown of academic impact, for papers by Duha Al‐Zubeidi
Rankless by CCL
2026